PLOD2 and cancer: By calculating the proportion of immuno-staining with high, medium, low, or not detected in different cancer types as reported by HPA, we found DDX27 and PLOD2 showing medium to high tumor-specific staining in multiple cancer types (Additional file 5: Figures S4a-b).